JOINT FILING AGREEMENTJoint Filing Agreement • January 20th, 2022 • Linden Capital L.P. • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Revelation Biosciences, Inc. dated as of January 14, 2022 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
